CNM-Au8 Seen to Raise Energy Metabolism of Brain in RRMS Trial
Reposted from Multiple Sclerosis News Today
An investigational oral therapy termed CNM-Au8 which contains a suspension of nanocrystalline gold was tested on 11 adults with relapsing-remitting multiple sclerosis (RRMS). The study’s main goal was to measure changes in the ratio of two metabolic markers, NAD+ and NADH.